Shahid Ahmed and his newly formed company, Nexus Pharmaceuticals, developed injectable drugs based on the confidential information Ahmed gleaned from a competitor, Bioniche Pharma claims in Lake County Court.
Two patent infringement complaints filed in Newark Federal Court seek to block Lupin Pharmaceuticals and Lupin Limited from obtaining FDA approval to sell a generic version of Tricor before the original patent expires.
Categories / Uncategorized
Subscribe to Closing Arguments
Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.